Gottlieb Resignation Leaves Key Supplement Rules in Limbo
FDA Commissioner Scott Gottlieb’s surprise resignation earlier this month sent shockwaves through the natural products industries. His departure at the end of March will leave two key aspects of dietary supplement regulation in limbo: the legality of CBD supplements, and the possibility of a major revision of the Dietary Supplement Health and Education Act (DSHEA).